Evidence map›Paper›PMID 28263564›Full record

ArticleACS nano2017

Theranostic Multilayer Capsules for Ultrasound Imaging and Guided Drug Delivery.

Jun Chen, Sithira Ratnayaka, Aaron Alford, Veronika Kozlovskaya, Fei Liu, Bing Xue, Kenneth Hoyt, Eugenia Kharlampieva

Open access · greenAbstract read
In one paragraph

Article in ACS nano, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 102 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Crosslinked polymer nanocapsules for therapeutic, diagnostic, and theranostic applications.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2020
    Review
  17. Ultrasound-Activated Nanomaterials for Therapeutics.Bulletin of the Chemical Society of Japan · 2020
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jun ChenDepartment of Chemistry, University of Alabama at Birmingham , Birmingham, Alabama 35294, United States.
Sithira RatnayakaDepartment of Chemistry, University of Alabama at Birmingham , Birmingham, Alabama 35294, United States.
Aaron AlfordDepartment of Chemistry, University of Alabama at Birmingham , Birmingham, Alabama 35294, United States.
Veronika KozlovskayaDepartment of Chemistry, University of Alabama at Birmingham , Birmingham, Alabama 35294, United States.
Fei LiuDepartment of Chemistry, University of Alabama at Birmingham , Birmingham, Alabama 35294, United States.
Bing XueDepartment of Chemistry, University of Alabama at Birmingham , Birmingham, Alabama 35294, United States.
Kenneth HoytDepartment of Bioengineering, University of Texas at Dallas , Richardson, Texas 75080, United States.
Eugenia KharlampievaDepartment of Chemistry, University of Alabama at Birmingham , Birmingham, Alabama 35294, United States.ORCID 0000-0003-0227-0920
University of Alabama at Birmingham · USThe University of Texas at Dallas · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
Molecular Ultrasound Imaging of Cancer Response to Antiangiogenic TherapyK25EB017222 · NIBIB · UNIVERSITY OF TEXAS DALLAS · PI HOYT, KENNETH · 2014 to 2018
$804k
Noninvasive Pressure Estimation in Breast Cancer using UltrasoundR21CA212851 · NCI · UNIVERSITY OF TEXAS DALLAS · PI HOYT, KENNETH · 2017 to 2018
$366k
NCI NIH HHS P30 CA013148NCI NIH HHS R21 CA212851NIBIB NIH HHS K25 EB017222
6 · The paper itself

Abstract

Despite the accessibility of ultrasound, the clinical potential of ultrasound-active theranostic agents has not been fully realized because it requires combining sufficient imaging contrast, high encapsulation efficiency, and ultrasound-triggered release in one entity. We report on theranostic polymer microcapsules composed of hydrogen-bonded multilayers of tannic acid and poly(N-vinylpyrrolidone) that produce high imaging contrast and deliver the anticancer drug doxorubicin upon low-power diagnostic or high-power therapeutic ultrasound irradiation. These capsules exhibit excellent imaging contrast in both brightness and harmonic modes and show prolonged contrast over six months, unlike commercially available microbubbles. We also demonstrate low-dose gradual and high-dose fast release of doxorubicin from the capsules by diagnostic (∼100 mW/cm

Indexed as

Breast NeoplasmsDrug Delivery SystemsTheranostic NanomedicineUltrasonicsAntibiotics, AntineoplasticCapsulesCell ProliferationCell SurvivalContrast MediaDose-Response Relationship, DrugDoxorubicinDrug CarriersDrug Screening Assays, AntitumorHumansMCF-7 CellsOptical ImagingAntibiotics, AntineoplasticCapsulesContrast MediaDoxorubicinDrug CarriersPovidoneTanninsdoxorubicindrug deliveryhydrogen-bondedmultilayertannic acidultrasound

Identifiers

PMID28263564
PMCPMC5682940
OpenAlexW2593463573

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.